BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/22/2014 5:28:00 PM | Browse: 1518 | Download: 1616
Publication Name World Journal of Clinical Oncology
Manuscript ID 9658
Country United Kingdom
ISSN 2218-4333 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Minireviews
Article Title Pleomorphic lobular carcinoma in situ of the breast: Can the evidence guide practice?
Manuscript Source Invited Manuscript
All Author List Andrew Pieri, James Harvey and Nigel Bundred
Funding Agency and Grant Number
Corresponding Author Nigel Bundred, MD, FRCS, Professor of Surgical Oncology, Nightingale Centre, University Hospital of South Manchester, Wythenshawe Hospital, Southmoor Road, Manchester, M23 9LT, United Kingdom. nigel.j.bundred@manchester.ac.uk
Key Words Pleomorphic lobular carcinoma in situ; Breast cancer; Breast carcinoma; Carcinoma in situ; Guideline; Excision margin; Recurrence rate
Core Tip Pleomorphic lobular carcinoma in situ (PLCIS) is a breast lesion, the clinical significance of which is a subject of controversy. To date, this systematic review is the largest pooled series of clinical data regarding PLCIS. We aimed to establish whether current guidelines for management are consistent with the evidence. The results demonstrate a lack of high quality data and guidelines for management are variable. Analysis revealed a high incidence of concurrent invasive disease with PLCIS (49%) and following excision, a recurrence rate of 9.4%. We conclude that it would seem prudent to manage PLCIS as with ductal carcinoma in situ, although there is a dire need for long-term outcome studies.
Publish Date 2014-08-01 15:17
Citation Pieri A, Harvey J, Bundred N. Pleomorphic lobular carcinoma in situ of the breast: Can the evidence guide practice? World J Clin Oncol 2014; 5(3): 546-553
URL http://www.wjgnet.com/2218-4333/full/v5/i3/546.htm
DOI http://dx.doi.org/10.5306/wjco.v5.i3.546
Full Article (PDF) WJCO-5-546.pdf
Full Article (Word) WJCO-5-546.doc